Basket | Login | Register


CTAD Lifetime Achievement Award goes to Zaven Khachaturian for his work on the foundations of AD clinical trials

Wednesday 04 December 2019

On 4 December, the Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research was awarded to Zaven Khachaturian at the 2019 Clinical Trials on Alzheimer’s Disease (CTAD) conference. Zaven Khachaturian is the President of Prevent Alzheimer’s Disease 2020, as well as a Senior Science Advisor to the Alzheimer's Association (US). He is also the Editor-in-Chief of Alzheimer's & Dementia: Journal of the Alzheimer's Association.

Dr Khachaturian has made many important scientific contributions to our understanding of Alzheimer’s disease (AD). Following his training in neurophysiology at Yale and Case Western Reserve University, he was one of the first scientists to propose a connection between altered calcium homeostasis and AD. He also contributed to the earliest diagnostic criteria for AD, working as Associate Director then Director of the Office of Alzheimer’s Research at the US National Institutes of Health (1977-1995). Previous awardees of the CTAD Lifetime Achievement Award include Rachelle Doody (Global Head of Neurodegeneration for Genentech and Roche), Gordon Wilcock (Professor of Geronotology at the University of Oxford) and Bruno Dubois (Professor of Neurology at Pitié-Salpêtrière University Hospital).